Codetta Bio: Funding, Investors & Team (Oct 2026)
Codetta Bio is a life sciences company developing an innovative analysis platform using digital spatial polymerase chain reaction (dsPCR) and digital spatial immuno polymerase chain reaction (dsIPCR). This platform integrates reagents, hardware, and software to allow for multiplexed, multi-omic liquid biopsy and analysis of DNA, RNA, and proteins. The company's goal is to offer a dsPCR solution that speeds up research for new therapies, ultimately enhancing patient care and quality of life in the life sciences field.
Codetta Bio has raised $2.3M across 1 funding round on record, the most recent an undisclosed round of $2.3M announced in Jun 2024.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Codetta Bio Company Profile and Key Stats
Latest funding round on record: Jun 2024.
Codetta Bio Funding Rounds
Codetta Bio Founders and Leadership Team
Contact details for the Codetta Bio team: 1 of 1 has an email address on file.
Start 14-day free trial →Codetta Bio Funding Compared to Other Biotechnology Startups
Codetta Bio's latest round of $2.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Codetta Bio in Biotechnology and Durham
Companies Similar to Codetta Bio
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Codetta Bio Funding FAQs
What does Codetta Bio do?
Codetta Bio is a life sciences company developing an innovative analysis platform using digital spatial polymerase chain reaction (dsPCR) and digital spatial immuno polymerase chain reaction (dsIPCR). This platform integrates reagents, hardware, and software to allow for multiplexed, multi-omic liquid biopsy and analysis of DNA, RNA, and proteins. The company's goal is to offer a dsPCR solution that speeds up research for new therapies, ultimately enhancing patient care and quality of life in the life sciences field.
How much funding has Codetta Bio raised?
Codetta Bio has raised $2.3M across 1 round on record. The most recent is an undisclosed round of $2.3M announced in Jun 2024.
When did Codetta Bio last raise funding?
Codetta Bio's most recent funding round on record is an undisclosed round of $2.3M, announced in Jun 2024.
Who founded Codetta Bio?
FundedIQ lists William Henley (Founder) at Codetta Bio.
Where is Codetta Bio headquartered?
Codetta Bio is based in Durham, North Carolina, United States.
How many employees does Codetta Bio have?
Codetta Bio is in the 11-50 employee band.
How does Codetta Bio's funding compare to other Biotechnology startups?
Codetta Bio's latest round of $2.3M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Codetta Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Codetta Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.